These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 17010193)

  • 1. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the ATR gene in breast and ovarian cancer families.
    Heikkinen K; Mansikka V; Karppinen SM; Rapakko K; Winqvist R
    Breast Cancer Res; 2005; 7(4):R495-501. PubMed ID: 15987455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
    Plourde M; Manhes C; Leblanc G; Durocher F; Dumont M; Sinilnikova O; ; Simard J
    J Mol Endocrinol; 2008 Apr; 40(4):161-72. PubMed ID: 18372405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families.
    Montagna M; Santacatterina M; Corneo B; Menin C; Serova O; Lenoir GM; Chieco-Bianchi L; D'Andrea E
    Cancer Res; 1996 Dec; 56(23):5466-9. PubMed ID: 8968102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
    Montagna M; Santacatterina M; Torri A; Menin C; Zullato D; Chieco-Bianchi L; D'Andrea E
    Oncogene; 1999 Jul; 18(28):4160-5. PubMed ID: 10435598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
    Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
    Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
    Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
    Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
    Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
    Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
    Plourde M; Samson C; Durocher F; Sinilnokova O; Simard J;
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):115-28. PubMed ID: 18083510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
    Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of ATM mutations to familial breast and ovarian cancer.
    Thorstenson YR; Roxas A; Kroiss R; Jenkins MA; Yu KM; Bachrich T; Muhr D; Wayne TL; Chu G; Davis RW; Wagner TM; Oefner PJ
    Cancer Res; 2003 Jun; 63(12):3325-33. PubMed ID: 12810666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.
    Jakubowska A; Górski B; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Debniak T; Hadaczek P; Scott RJ; Lubinski J
    Hum Mutat; 2001 Aug; 18(2):149-56. PubMed ID: 11462239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
    Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
    Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
    Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.